IGF2BP2 and colorectal carcinoma: In colorectal carcinoma, m6A‐methylated SOX2 mRNA was recognized by IGF2BP2, which suppressed RNA degradation of SOX2.16 This study showed that IGF2BP2 or METTL3 knockdown significantly decreased the half‐life of PCAT6 in an m6A‐dependent manner, consistent with previous findings.